Target Price | $20.67 |
Price | $6.01 |
Potential |
243.87%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Tenax Therapeutics, Inc. 2026 .
The average Tenax Therapeutics, Inc. target price is $20.67.
This is
243.87%
register free of charge
$30.00
399.17%
register free of charge
$16.00
166.22%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Tenax Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Tenax Therapeutics, Inc. stock has an average upside potential 2026 of
243.87%
register free of charge
|
Analyst | Rating | Action | Date |
---|---|---|---|
Leerink Partners | Locked ➜ Locked | Locked | Oct 24 2024 |
Guggenheim | Locked ➜ Locked | Locked | Oct 14 2024 |
William Blair | Locked ➜ Locked | Locked | Sep 30 2024 |
Analyst Rating | Date |
---|---|
Locked
Leerink Partners: Locked ➜ Locked
|
Oct 24 2024 |
Locked
Guggenheim: Locked ➜ Locked
|
Oct 14 2024 |
Locked
William Blair: Locked ➜ Locked
|
Sep 30 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.